MedicinesFAQ

AGS-005 Uses, Dosage, Side Effects and more

AGS-005 is a personalized dendritic cell-based immunotherapy, with optimized immune response characteristics, that is designed to stimulate the patient's immune system to target and destroy the patient's cancer cells.

Attribute Details
Trade Name AGS-005
Generic AGS-005
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am
   

Uses

Investigated for use/treatment in leukemia (lymphoid).

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.